# Proof of Concept Study on BP1.4979 Effect on Essential Tremor

> **NCT07074002** · PHASE2 · RECRUITING · sponsor: **Bioprojet** · enrollment: 50 (estimated)

## Conditions studied

- Essential Tremor

## Interventions

- **DRUG:** BP1.4979
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07074002
- **Lead sponsor:** Bioprojet
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-17
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07074002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07074002, "Proof of Concept Study on BP1.4979 Effect on Essential Tremor". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07074002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*